Tomer is the Israeli General Partner at Camelot BioCapital.
He is a serial entrepreneur and venture builder specializing in healthcare, biotech, and deep tech innovation.
His first equity deal was with NYX Technologies, a leading neuroscience tech company he co-founded in 2016, where he has served as CEO and chairman since its inception.
Prior to founding NYX, Tomer was the executive director of the Technion’s BizTEC accelerator, where he directly supported more than 60 deep tech ventures.
He now leads the Technion’s BizTEC alumni organization, representing a network of over 2,000 tech entrepreneurs built over two decades of innovation. Tomer is an 8200 EISP alumnus, a Merage Institute alumnus, and an XTC finalist.
